Telemetry Investments’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,000
| Closed | -$344K | – | 210 |
|
|
2021
Q3 | $344K | Buy |
+2,000
| New | +$344K | 0.46% | 72 |
|
|
2018
Q3 | – | Sell |
-7,500
| Closed | -$364K | – | 144 |
|
|
2018
Q2 | $364K | Buy |
+7,500
| New | +$364K | 0.14% | 52 |
|
|
2018
Q1 | – | Sell |
-9,500
| Closed | -$403K | – | 151 |
|
|
2017
Q4 | $403K | Sell |
9,500
-16,110
| -63% | -$683K | 0.15% | 43 |
|
|
2017
Q3 | $956K | Sell |
25,610
-9,069
| -26% | -$339K | 0.34% | 29 |
|
|
2017
Q2 | $1.05M | Buy |
34,679
+6,709
| +24% | +$204K | 0.5% | 27 |
|
|
2017
Q1 | $740K | Sell |
27,970
-8,560
| -23% | -$226K | 0.33% | 31 |
|
|
2016
Q4 | $932K | Buy |
36,530
+24,530
| +204% | +$626K | 0.53% | 25 |
|
|
2016
Q3 | $434K | Sell |
12,000
-6,500
| -35% | -$235K | 0.27% | 42 |
|
|
2016
Q2 | $629K | Sell |
18,500
-20,000
| -52% | -$680K | 0.34% | 35 |
|
|
2016
Q1 | $1.02M | Buy |
38,500
+30,570
| +385% | +$807K | 0.3% | 36 |
|
|
2015
Q4 | $387K | Sell |
7,930
-46,770
| -86% | -$2.28M | 0.13% | 75 |
|
|
2015
Q3 | $1.36M | Buy |
54,700
+700
| +1% | +$17.4K | 0.58% | 40 |
|
|
2015
Q2 | $1.71M | Buy |
54,000
+34,500
| +177% | +$1.09M | 0.77% | 26 |
|
|
2015
Q1 | $742K | Buy |
19,500
+10,500
| +117% | +$400K | 0.41% | 44 |
|
|
2014
Q4 | $351K | Buy |
+9,000
| New | +$351K | 0.22% | 94 |
|